Resistant strains of bacteria feared from repeated use of ophthalmic antibiotics

Article

According to data recently published, repeated use of ophthalmic antibiotics post intraocular injections will cause an increase in incidences of resistant strains of conjunctival flora.

According to data recently published in Archives of Ophthalmology, repeated use of ophthalmic antibiotics post intraocular injections will cause an increase in incidences of resistant strains of conjunctival flora.

The study performed by Drs Stephen Kim and Hassanain Toma (Vanderbilt Eye Institute, Department of Ophthalmology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA) examined 48 eyes of 24 patients who were being treated for choroidal neovascularization (CNV) with unilateral intraocular injection.

Conjunctival cultures were taken bilaterally from both eyes (treated and untreated) at baseline and after each injection. All patients were randomly assigned to one of four different antibiotics and used only that antibiotic after each injection. Antibiotic susceptibility of the bacterial isolates was measured for 16 various antibiotics and pulse-field gel electrophoresis was used to analyse the bacteria DNA.

It was found that significant increases in drug resistance occurred in treated eyes, which led the team to conclude that conjunctival flora that is repeatedly exposed to antibiotics will result in resistant strains.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
© 2025 MJH Life Sciences

All rights reserved.